BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 8506803)

  • 1. [Intracavernous injection of lipo prostaglandin E1 for the diagnosis of impotence: a comparative study with prostaglandin E1-CD].
    Yajima M; Baba K; Minagawa N; Kohno S; Haraguchi C; Iwamoto T; Osada T
    Hinyokika Kiyo; 1993 Mar; 39(3):289-92. PubMed ID: 8506803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of sexual impotency by intra-cavernous injections of prostaglandin E1. Report of 180 patients].
    Amar E; Kobelinsky M; Khoury R; Sarkis P; Bouyer I; Dauphin A; Delmas V; Boccon-Gibod L
    Prog Urol; 1993 Dec; 3(6):971-8. PubMed ID: 8305940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An attempt to standardize the pharmacological diagnostic screening of vasculogenic impotence with prostaglandin E1.
    McMahon CG
    Int J Impot Res; 1995 Jun; 7(2):83-90. PubMed ID: 7496445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intracavernous injections of prostaglandin E1 in the treatment of erection disorders].
    Beretta G; Zanollo A; Portalupi W
    Arch Ital Urol Nefrol Androl; 1991 Dec; 63(4):481-5. PubMed ID: 1838836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intracavernous injection of prostaglandin E1 as a diagnostic test in erectile dysfunction].
    Marín Lafuente JC; Sańchez Moreno Horencia M; Puy Figuero Echeverría M; Llarena Ibarguren R; Pertusa Peña C
    Arch Esp Urol; 1990; 43(6):661-3. PubMed ID: 2092621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study with intracavernous injection of prostaglandin E1 versus papaverine for the diagnostic assessment of erectile impotence.
    Wang CJ; Wu CC; Huang CH; Chiang CP
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Nov; 8(11):585-90. PubMed ID: 1296038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostaglandin E1 in the diagnosis and therapy of erectile disorders].
    Loran OB; Segal AS; Shcheplev PA
    Urol Nefrol (Mosk); 1995; (4):35-8. PubMed ID: 7571200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Initial experiences with prostaglandin E1 and PGE1 prepared injections].
    Mattarelli G; Leibundgut B
    Helv Chir Acta; 1991 Sep; 58(3):335-7. PubMed ID: 1769856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dose adaptation during training of intracavernous self-injections of prostaglandin E1].
    Staerman F; Veilhan LA; Guiraud P; Coeurdacier P; Cipolla B; Lobel B
    Prog Urol; 1996; 6(4):564-8. PubMed ID: 8924934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erectile response to intracavernous injection of linsidomine in 38 impotent patients. Comparison with prostaglandin E1].
    Lemaire A; Buvat J
    Prog Urol; 1998 Jun; 8(3):388-91. PubMed ID: 9689672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intracavernous auto-injection of prostaglandin E1 for diagnosis and treatment of erectile dysfunction].
    Arielly J; Weinberg D; Eliraz A; Adam M; el-Hanani BI; Eisenkraft S
    Harefuah; 1994 Apr; 126(7):369-73, 426. PubMed ID: 8200581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostaglandin E1 in erectile dysfunction].
    Porst H
    Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lowest effective dose of prostaglandin E1 as treatment for erectile dysfunction.
    Chen J; Godschalk M; Katz PG; Mulligan T
    J Urol; 1995 Jan; 153(1):80-1. PubMed ID: 7966797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracavernous injection of prostaglandin E1: the application to cavernosography and penile blood flow measurement for the diagnosis of venogenic impotence.
    Ishigooka M; Irisawa C; Watanabe H; Adachi M; Ishii N; Nakada T
    Urol Int; 1991; 46(2):193-6. PubMed ID: 2053230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy and safety of self-intracavernous injection of prostaglandin E1 for treatment of erectile dysfunction in China.
    He L; Wen J; Jiang X; Chen H; Tang Y
    Andrologia; 2011 Jun; 43(3):208-12. PubMed ID: 21486416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracavernous injection of prostaglandin E1 in spinal cord injured patients with erectile dysfunction. A preliminary report.
    Tang SF; Chu NK; Wong MK
    Paraplegia; 1995 Dec; 33(12):731-3. PubMed ID: 8927414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.
    Maniam P; Seftel AD; Corty EW; Rutchik SD; Hampel N; Althof SE
    J Urol; 2001 Mar; 165(3):830-2; discussion 832-3. PubMed ID: 11176480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of prostaglandin El in the diagnosis of erectile dysfunction in comparison with papaverine and papaverine/phentolamine in 61 patients with erectile dysfunction].
    Porst H
    Urologe A; 1988 Jan; 27(1):22-6. PubMed ID: 3284144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.